Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...

Fox News host and meteorologist Janice Dean said she is taking a break from work to be with her family amid "health issues." ...

What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...

After 30 years of living with Multiple Sclerosis (MS), country music star Clay Walker shared that the disease has recently ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...